Clinical Trial Update: Erlotinib in Treating Patients With Barrett Esophagus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating erlotinib for Barrett's esophagus (a precancerous condition of the esophagus), with the current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Kansas City Veteran Affairs Medical Center | Conditions: Esophageal Cancer, Precancerous Condition | Phase 1 | Status: UNKNOWN